Filing Flows › Sensus Healthcare (SRTS) › Q1 2026 › vs Q1 2025
Sensus Healthcare (SRTS) Q1 2026 vs Q1 2025 (year over year)
Sensus Healthcare's revenue fell $5.0M (-59%) from $8.3M in Q1 2025 to $3.4M in Q1 2026. The biggest changes: Product −$5.1M (-75%); Product Revenue +$144K (+72%); Service −$101K (-16%).
Sensus Healthcare, Q1 2026: revenue $3.4M (-59% year over year), operating margin -128.4%, net loss $2.6M, operating cash flow −$3.8M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Product | $1.7M | $6.7M | −$5.1M | -75% |
| Service Revenue | $875K | $813K | $62K | +8% |
| Service | $523K | $624K | −$101K | -16% |
| Product Revenue | $343K | $199K | $144K | +72% |
| Revenue | $3.4M | $8.3M | −$5.0M | -59% |
| Other income, net | $125K | $184K | −$59K | -32% |
| Income tax benefit | $1.6M | −$110K | $1.7M | — |
| Net loss | $2.6M | $2.6M | $54K | +2% |
| Costs & expenses | $7.8M | $11.1M | −$3.3M | -30% |
| Operating costs | $7.8M | $11.0M | −$3.2M | -29% |
| Cost of revenue | $2.4M | $4.0M | −$1.6M | -40% |
| Research & development | $1.6M | $2.6M | −$1.0M | -39% |
| SG&A | $2.0M | $2.2M | −$165K | -7% |
| Other operating costs | $1.7M | $2.2M | −$470K | -22% |
| Operating cash sources | $3.9M | $2.8M | $1.1M | +38% |
| Depreciation | $96K | $86K | $10K | +12% |
| Share-based compensation | $70K | $79K | −$9K | -11% |
| Cash used in operations | $3.8M | $2.7M | $1.1M | +40% |
| Net loss absorbed | $2.6M | $2.6M | $54K | +2% |
| Working capital & other | $1.3M | $270K | $1.0M | +379% |
Questions
How much did Sensus Healthcare's revenue grow year over year in Q1 2026?
Sensus Healthcare's revenue fell $5.0M (-59%) from $8.3M in Q1 2025 to $3.4M in Q1 2026.
What drove Sensus Healthcare's revenue change in Q1 2026?
Product −$5.1M (-75%); Product Revenue +$144K (+72%); Service −$101K (-16%).